{
    "applicationNumber": "BR 11 2020 023264-5",
    "filingDate": "15/05/2019",
    "grantDate": null,
    "title": "ANTICORPOS BIESPEC\u00cdFICOS DE BCMA/CD3 E GPRDC5D/CD3 PARA USO EM TERAPIA DE C\u00c2NCER",
    "nationalPhaseDate": [
        "13/11/2020"
    ],
    "internationalApplication": {
        "pctNumber": "PCT IB2019/054033",
        "pctDate": "15/05/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/672,222",
            "priorityDate": "16/05/2018"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/736,804",
            "priorityDate": "26/09/2018"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/842,080",
            "priorityDate": "02/05/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2603"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2616"
        },
        {
            "code": "15.35",
            "description": "Atualiza\u00e7\u00e3o de informa\u00e7\u00f5es no portal",
            "bulletinNumber ": "2658"
        }
    ],
    "inventors": [
        "HOMER ADAMS",
        "FRANCOIS GAUDET",
        "KRIS FRERICHS",
        "NIELS VAN DE DONK",
        "CHRISTIE VERKLEIJ"
    ],
    "holders": [
        80299,
        106991
    ],
    "ipcCodes": [
        "A61K 39/395",
        "C07K 16/30",
        "A61K 39/00",
        "C07K 16/28",
        "A61K 45/06"
    ]
}